In recent years, intraocular lenses (IOLs) have been increasingly used in the correction of aphakia after congenital cataract extraction. But IOL implantation in infants and young children, especially under 1 year old, is still controversy. Large-scale, multi-center, randomly controlled clinical observations on this issue have been conducted. The mid-and long-term results have shown that infantile cataract extraction combined with primary IOL implantation can achieve the same or better visual outcome as aphakic contact lens correction. For infants over 7 months of age and young children, primary implantation of IOLs is relatively safe, with a low complication and secondary operation rate. Compared to the way of aphakic contact lens correction, which could be with more inconvenience, high demand of coordination, a higher infection risk, high cost and the need of a secondary IOL implantation surgery, primary implantation of IOLs at over 7 months of age is worth exploring, with appropriate understanding of the surgical indications and adequate surgical techniques. (Chin J Ophthalmol, 2021, 57: 487-491).
近年来,人工晶状体(IOL)越来越多地应用于婴幼儿白内障摘除术后无晶状体眼的屈光矫正,但婴幼儿特别是1岁以下婴儿期行IOL植入术仍存在争议。最近国际权威研究对此进行了大样本、多中心、对照性临床观察,中、远期结果显示婴幼儿期白内障摘除联合一期IOL植入可达到与无晶状体眼接触镜矫正同等或者更好的视力预后。对于7月龄以上婴幼儿,IOL一期植入手术较为安全,并发症和再次手术率低。相较于角膜接触镜配戴的不便利、难配合、感染风险、高昂费用和增加二期植入手术,在选择好适应证和掌握手术技术的情况下,7月龄以上婴幼儿白内障IOL一期植入值得探索。(中华眼科杂志,2021,57:487-491).